Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × abemaciclib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 26 Endometrial Neoplasms 6 Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Glioblastoma 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Brain Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Retinoblastoma 1 Recurrence 1 Pathologic Complete Response 1 Osteosarcoma 1 Oligodendroglioma 1 Neoplasms, Squamous Cell 1 Neoplasm, Residual 1 Multiple Myeloma 1 Metastatic Castration-Resistant Prostate Cancer 1 Mesothelioma, Malignant 1 Meningioma 1

Interventions

Cyclophosphamide 33 fludarabine 29 Tacrolimus 23 Whole-Body Irradiation 22 Mycophenolic Acid 21 Busulfan 20 fludarabine phosphate 18 Melphalan 16 thymoglobulin 14 Antilymphocyte Serum 14 Thiotepa 11 Methotrexate 11 Stem Cell Transplantation 8 Rituximab 7 Granulocyte Colony-Stimulating Factor 7 Sirolimus 6 Filgrastim 6 trametinib 5 ruxolitinib 4 merphos 4 Nivolumab 4 Cytarabine 4 Cyclosporine 4 Cord Blood Stem Cell Transplantation 4 fedratinib 3 ceritinib 3 angiotensin I (1-7) 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Pentostatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡